CD45 fraction bone marrow cells as potential delivery vehicles for genetically corrected dystrophin loci

Neuromuscular Disorders

Volumn 12, Issue SUPPL., 2002, Pages

  Kapsa, R M I ^a,b   Wong, S H A ^a,b   Bertoncello, I ^c   Quigley, A F ^a,b   Williams, B ^c   Sells, K ^c   Marotta, R ^a,b   Kita, M ^a,b   Simmons, P ^c   Byrne, E ^a,b   Kornberg, A J ^a,b  

^a ST VINCENT S HOSPITAL   (Australia)

^b FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^c PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

Bone marrow cells; Duchenne dystrophy; Dystrophin

Indexed keywords

CD45 ANTIGEN; DNA; DYSTROPHIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; BONE MARROW CELL; CELL ASSAY; CHIMERAPLASTY; CONFERENCE PAPER; CONTROLLED STUDY; DYSTROPHY; EXON; GENE DELIVERY SYSTEM; GENE LOCUS; GENE SEQUENCE; GENE TARGETING; GENETIC PARAMETERS; GENETIC PROCEDURES; ISOLATION PROCEDURE; METHODOLOGY; MOUSE; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, CD45; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CELL TRANSPLANTATION; DYSTROPHIN; FRAMESHIFT MUTATION; GENE TARGETING; GENE THERAPY; GENE TRANSFER TECHNIQUES; MICE; MICE, INBRED C57BL; MICE, INBRED MDX; MUSCULAR DYSTROPHIES; MUSCULAR DYSTROPHY, ANIMAL; MUSCULAR DYSTROPHY, DUCHENNE;

EID: 0036823757     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-8966(02)00084-6     Document Type: Conference Paper

References (15)

1. Rando T.A., Disatnik M.H., Zhou L.Z. Rescue of dystrophin expression in mdx mouse muscle by RNA/DNA oligonucleotides. Proc Natl Acad Sci USA. 97:2000;5363-5368.
2. Kapsa R., Quigley A., Lynch G.S., et al. In vivo and in vitro correction of the mdx dystrophin gene nonsense mutation by short-fragment homologous replacement. Hum Gene Ther. 12:2001;629-642.
3. Ferrari G., Cusella-De Angelis G., et al., Muscle regeneration by bone marrow-derived myogenic progenitors. Science. 279:1998;1528-1530.
4. Bittner R.E., Schofer C., Weipoltshammer K., et al. Recruitment of bone-marrow-derived cells by skeletal and cardiac muscle in adult dystrophic mdx mice. Anat Embryol (Berlin). 199:1999;391-396.
5. Gussoni E., Soneoka Y., Strickland C.D., et al. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature. 401:1999;390-394.
6. Kapsa R.M., Quigley A.F., Vadolas J., et al. Targeted gene correction in the mdx mouse using short DNA fragments: towards application with bone marrow-derived cells for autologous remodelling of dystrophic muscle. Gene Ther. 9:(11):2002;695-699.
7. Rando T.A., Blau H.M. Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy. J Cell Biol. 125:1994;1275-1287.
8. Vilquin J.T., Wagner E., Kinoshita I., Roy R., Tremblay J.P. Successful histocompatible myoblast transplantation in dystrophin-deficient mdx mouse despite the production of antibodies against dystrophin. J Cell Biol. 131:1995;975-988.
9. Huard J., Verreault S., Roy R., Tremblay M., Tremblay J.P. High efficiency of muscle regeneration after human myoblast clone transplantation in SCID mice. J Clin Invest. 93:1994;586-599.
10. Lee J.Y., Qu-Petersen Z., Cao B., et al. Clonal isolation of muscle-derived cells capable of enhancing muscle regeneration and bone healing. J Cell Biol. 150:2000;1085-1100.
11. Torrente Y., Tremblay J.P., Pisati F., et al. Intraarterial injection of muscle-derived CD34(+)Sca-1(+) stem cells restores dystrophin in mdx mice. J Cell Biol. 152:2001;335-348.
12. Bertoncello I., Bradford G.B. Surrogate assays for hematopoietic stem cell activity. Garland J., Quesenberry P., Hilton D. Colony-stimulating factors. 1997;35-47 Marcel Dekker, New York, NY. [chap 2].
13. Bertoni C., Rando T.A. Dystrophin gene repair in mdx muscle precursors in vitro and in vivo mediated by RNA-DNA chimeric oligonucleotides. Hum Gene Ther. 13:2002;707-718.
14. Zuk P.A., Zhu M., Mizuno H., et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 7:2001;211-228.
15. Bower J., White J., Kurek J., Muldoon C.M., Austin L. The role of growth factors in myoblast transfer therapy. Basic Appl Myol. 7:1997;177-186.